Effective treatment of a platinum‑resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition

  • Authors:
    • Carlo Capalbo
    • Francesca Belardinilli
    • Marco Filetti
    • Claudia Parisi
    • Marialaura Petroni
    • Valeria Colicchia
    • Alessandra Tessitore
    • Matteo Santoni
    • Anna Coppa
    • Giuseppe Giannini
    • Paolo Marchetti
  • View Affiliations

  • Published online on: May 21, 2018     https://doi.org/10.3892/mco.2018.1634
  • Pages: 30-34
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cutaneous squamous cell carcinoma (cSCC) is the second most common type of non‑melanoma skin cancer. Platinum‑based regimens have been an integral part of palliative care for patients with locally advanced or metastatic disease. There is no evidence of efficacy for later lines of chemotherapy and no targeted therapy has been introduced as ‘standard of care’. Here we report on the case of an elderly cSCC patient, resistant to conventional therapy, however successfully treated with anti‑epidermal growth factor receptor (EGFR) agent (Cetuximab) in addition to a daily dose of Curcumin phospholipid. The patient responded to treatment and experienced no recurrence for 11 months with only minor skin‑related toxicity. To our knowledge, this is the first report of clinical evidence that an anti EGFR targeted therapy with a daily oral dose of Curcumin phospholipid is well tolerated and results in a highly effective disease control in a heavily pretreated cSCC patient.
View Figures
View References

Related Articles

Journal Cover

July-2018
Volume 9 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Capalbo C, Belardinilli F, Filetti M, Parisi C, Petroni M, Colicchia V, Tessitore A, Santoni M, Coppa A, Giannini G, Giannini G, et al: Effective treatment of a platinum‑resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition. Mol Clin Oncol 9: 30-34, 2018
APA
Capalbo, C., Belardinilli, F., Filetti, M., Parisi, C., Petroni, M., Colicchia, V. ... Marchetti, P. (2018). Effective treatment of a platinum‑resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition. Molecular and Clinical Oncology, 9, 30-34. https://doi.org/10.3892/mco.2018.1634
MLA
Capalbo, C., Belardinilli, F., Filetti, M., Parisi, C., Petroni, M., Colicchia, V., Tessitore, A., Santoni, M., Coppa, A., Giannini, G., Marchetti, P."Effective treatment of a platinum‑resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition". Molecular and Clinical Oncology 9.1 (2018): 30-34.
Chicago
Capalbo, C., Belardinilli, F., Filetti, M., Parisi, C., Petroni, M., Colicchia, V., Tessitore, A., Santoni, M., Coppa, A., Giannini, G., Marchetti, P."Effective treatment of a platinum‑resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition". Molecular and Clinical Oncology 9, no. 1 (2018): 30-34. https://doi.org/10.3892/mco.2018.1634